Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS)

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 5, 2013, Pages 826-835

  Gando, S ^a   Wada, H ^b   Thachil, J ^c  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Coagulopathy; Disseminated intravascular coagulation (DIC); Fibrinolysis; Protein C; Thrombomodulin; Trauma

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOGEN; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE COAGULOPATHY OF TRAUMA SHOCK; BLOOD CLOTTING DISORDER; COAGULOPATHY OF TRAUMA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INJURY; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; WOUND HEALING;

BLOOD COAGULATION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRINOLYSIS; HEMOSTASIS; HUMANS; PHENOTYPE; SHOCK, TRAUMATIC; WOUND HEALING;

EID: 84877896662     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12190     Document Type: Review

References (93)

1. Bouillon B, Brohi K, Hess JR, Holcomb JB, Parr MJ, Hoyt DB. Educational initiative on critical bleeding in Trauma: Chicago, July 11-13, 2008. J Trauma 2010; 68: 225-30.
2. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, Mackway-Jones K, Parr MJ, Rizoli SB, Yukioka T, Hoyt DB, Bouillon B. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65: 748-54.
3. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion. Modulated through the protein C pathway?. Ann Surg 2007; 245: 812-8.
4. Brohi K, Cohen MJ, Ganter MT, Schulz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-7.
5. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanisms, identification and effect. Curr Opin Crit Care 2007; 13: 680-5.
6. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Haemost 2001; 27: 585-91.
7. Gando S. Acute coagulopathy of trauma shock and coagulopathy of trauma: a rebuttal. You are going down the wrong path. J Trauma 2009; 67: 381-3.
8. Gando S, Sawamura S, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation. Ann Surg 2011; 254: 10-9.
9. Curry N, Stanworth S, Hopewell S, Dorée C, Brohi K, Hyde C. Trauma-induced coagulopathy - A review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice? Transfu Med Rev 2011; 25: 217-31.
10. Gando S, Wada H, Kim HK, Kurosawa S, Nielsen JD, Thachil J, Toh CH. Comparison of disseminated intravascular coagulation (DIC) in trauma with coagulopathy of trauma/acute coagulopathy of trauma-shock (COT/ACOTS). J Thromb Haemost 2012; 10: 2593-5.
11. Floccard B, Rugeri L, Faure A, Denis MS, Boyle EM, Peguet O, Levrat A, Guillaume C, Marcotte G, Vulliez A, Hautin E, David JS, Négrier C, Allaouchiche B. Early coagulopathy in trauma patients: an on scene and hospital admission study. Injury 2012; 43: 26-32.
12. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-30.
13. Ganter MT, Pittet JF. New insight into acute coagulopathy in trauma patients. Best Pract Res Clin Anesthesiol 2010; 24: 15-25.
14. Lier H, Böttiger BW, Hinkelbein J, Krep H, Bernhard M. Coagulation management in multiple trauma: a systematic review. Intensive Care Med 2011; 37: 572-82.
15. Levi M, ten Cate H, van der Poll T, van Daventer SJ. Pathogenesis of disseminated intravascular coagulation. JAMA 1993; 270: 975-9.
16. Marder VJ, Feinstein DI, Colman RW, Levi M. Consumptive thrombohemorrhagic disorders. In Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, 5th edn. Philadelphia: Lippincott Williams & Wilkins, 2006:1571-600.
17. Maruyama I, Sakata Y, Wada H, Asakura H, Okajima K, Gando S, Iba T, Uchiba M, Uchiyama T, Eguchi Y, Okamoto K, Ogura S, Kawasugi K, Kushimoto S, Koike K, Koga S, Seki Y, Madoiwa S, Mayumi T. Japanese Society of Thrombosis and Hemostasis Standardization Subcommittee for DIC. Expert consensus for the treatment of disseminated intravascular coagulation. Jpn J Thromb Hemost 2009; 20: 77-113.
18. Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 2009; 124: 608-13.
19. Murakami H, Gando S, Hayakawa M, Sawamura A, Sugano M, Kubota N, Uegaki S, Jesmin S. Disseminated intravascular coagulation at an early phase of trauma continuously proceeds to DIC at a late phase of trauma. Clin Appl Thromb Hemost 2012; 18: 364-9.
20. Turpini R, Stefanini M. The nature and mechanism of the hemostatic breakdown in the course of experimental hemorrhagic shock. J Clin Invest 1959; 38: 53-65.
21. Avikainen V, Eklund B. Disseminated intravascular coagulation after inhibition of fibrinolysis with tranexamic acid (AMCA) and proteinase inhibitor trasylol in experimental traumatic and hemorrhagic shock. Ann Chir Gynecol Fenn 1974; 63: 226-34.
22. Leandoer L, Bergentz SE. Haemorrhagic shock in the dog. The formation of thromboemboli during antifibrinolytic therapy. Eur Surg Res 1970; 2: 341-7.
23. Rizoli S, Nascimento B, Key N, Tien HC, Muraca S, Pinto R, Khalifa M, Plotkin A, Callum J. Disseminated intravascular coagulopathy in the first 24 hours after trauma: the association between ISTH score and anatomopathologic evidence. J Trauma 2011; 71: S441-7.
24. Nielsen VG. A comparison of the thromboelastograph and the ROTEM. Blood Coagl Fibrinolysis 2007; 18: 247-52.
25. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care devices. Anesth Analg 2008; 106: 1366-75.
26. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thromboelastography and thromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.
27. Rivard GE, Brummel K, Mann KG, Fann L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haemost 2005; 3: 2039-43.
28. Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, Attal RE, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM assays in sever blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. Br J Anaesth 2011; 107: 378-87.
29. Gando S, Tedo I, Kubota M. Posttrauma coagulation and fibrinolysis. Crit Care Med 1992; 20: 594-600.
30. Gando S, Nakanishi Y, Tedo I. Cytokines, plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 1995; 23: 1835-42.
31. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
32. Goris RJA. Pathophysiology of shock in trauma. Eur J Surg 2000; 166: 100-11.
33. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury 2007; 38: 1336-45.
34. Harris BH, Gelfand JA. The immune response to trauma. Semin Pediatric Surg 1995; 4: 77-82.
35. Nast-Kolb D, Waydhas C, Gippner-Steppert C, Trupka ISA, Ruchholtz S, Zettl R, Schweiberer L, Jochum M. Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma 1997; 42: 446-55.
36. Shaz BH, Winkler AM, James AB, Hillyer CD, MacLeod JB. Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma 2011; 70: 1401-7.
37. Engels PT, Rezende-Neto JB, Mahroos MA, Scarpelini S, Rizoli SB, Tien HC. The natural history of trauma-relaetd coagulopathy: implications for treatment. J Trauma 2011; 71: S448-55.
38. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, Gros A, Allouchiche B, Negrier C. Diagnosis of early coagulation abnormalities in trauma patients by rotation thromboelastography. J Thromb Haemost 2007; 5: 289-95.
39. Astrup T. Assay and content of tissue thromboplastin in different organs. Thromb Diasth Haemorrh 1965; 15: 401-16.
40. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134: 1087-97.
41. Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, Ikeda T, Ishikura H, Iba T, Ueyama M, Eguchi Y, Ohtomo Y, Okamoto K, Kushimoto S, Endo S, Shimazaki S. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008; 36: 145-50.
42. Bakhtiari K, Meijers JCM, De Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004; 32: 2416-21.
43. Toh CH, Hoots WK, on the behalf of the SCC on Disseminated Intravascular Coagulation of the ISTH. The scoring system of the Scientific and Standardization Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007; 5: 604-6.
44. Sawamura A, Hayakawa M, Gando S, Kubota N, Sugano M, Wada T, Katabami K. Application of the Japanese Association for Acute Medicine disseminated intravascular coagulation criteria for patients at an early phase of trauma. Thromb Res 2009; 124: 706-10.
45. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-8.
46. Erith D, Goslings JC, Gaader C, Maegele M, Cohen MJ, Allard S, Johansson PI, Stanworth S, Thiemermann C, Brohi K. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-25.
47. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptor 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879-87.
48. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74(Suppl. 2): 399-407.
49. Ho AMH, Karmaker MK, Dion PW. Are we giving enough coagulation factors during major trauma resuscitation? Am J Surg 2005; 190: 479-84.
50. Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma. Ann Surg 1999; 229: 121-7.
51. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transf Med Rev 2003; 17: 223-31.
52. Johansson PI, Sørensen AN, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care 2011; 15: R272.
53. Gando S, Kameue T, Nanzaki S, Hayakawa T, Nakanishi M. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory response syndrome. Crit Care Med 1997; 25: 1820-6.
54. Gando S, Nanzaki S, Morimoto Y, Ishitani T, Kemmotsu O. Tissue factor pathway inhibitor does not correlate with tissue-factor induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients. Crit Care Med 2001; 29: 262-6.
55. Lippi G, Cervellin G. Disseminated intravascular coagulation in trauma injuries. Semin Thromb Haemost 2010; 36: 378-87.
56. Engelman DT, Gabram SGA, Allen L, Ens GE, Jacobs LM. Hypercoagulability following trauma. World J Surg 1996; 20: 5-10.
57. Gando S, Nanzaki S, Sasaki S, Kemmotsu O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998; 79: 1111-5.
58. Johansson PI, Ostrowski SR. Acute coagulopathy of trauma: balancing progressive catecholamine induced endothelial activation and damage by fluid phase anticoagulation. Med Hypothesis 2010; 75: 564-7.
59. Dunbar NM, Chandler WL. Thrombin generation in trauma patients. Transfusion 2009; 49: 2652-60.
60. Chandler WL. Procoagulant activity in trauma patients. Am J Clin Pathol 2010; 134: 90-6.
61. Harr JN, Moor EE, Wohlauer MV, Droz N, Fragoso M, Banerjee A, Silliman CC. The acute coagulopathy of trauma is due to impaired initial thrombin generation but not clot formation or clot strength. J Sur Res 2011; 170: 319-24.
62. Schöchl H, Solomon C, Schulz A, Voelckel W, Hanke A, van Griensven M, Redl H, Bahrami S. Thromboelastometry (TEM) findings in disseminated intravascular coagulation in a pig model of endotoxemia. Mol Med 2011; 17: 266-72.
63. Sivula M, Pettilä V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagl Fibrinolysis 2009; 20: 419-26.
64. Sharma P, Saxena R. A novel thromboelastographic score to identify overt disseminated intravascular coagulation resulting in a hypocoagulable state. Am J Clin Pathol 2010; 134: 97-102.
65. Petersen LC, Valentin S, Hender U. Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor. Thromb Res 1995; 79: 1-47.
66. Gando S. Serial study of protein C in trauma patients. Jpn J Thromb Hesmost 1996; 7: 312-8.
67. Hayakawa M, Sawamura A, Gando S, Kubota N, Uegaki S, Shimojima H, Sugano M, Ieko M. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase. Surgery 2011; 149: 221-30.
68. Gando S, Kameue T, Matsuda N, Hayakawa M, Ishitani T, Morimoto Y, Kemmotsu O. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost 2002; 88: 943-9.
69. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clini Invest 1985; 76: 2178-81.
70. Ishii H, Ueyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-23.
71. Sawada K, Yamamoto H, Yago H, Suehiro S. A simple assay to detect endothelial cell injury: measurement of released thrombomodulin from cells. Exp Mol Pathol 1992; 57: 116-23.
72. Ogawa S, Shreeniwas R, Butura C, Brett J, Stern DM. Modulation of endothelial function by hypoxia: perturbation of barrier and anticoagulant function, and induction of a novel factor X activator. Adv Exp Med Biol 1990; 281: 303-12.
73. Ogawa S, Gerlach H, Esposito C, Pasagian-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest 1990; 85: 1090-8.
74. Öhlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost 2005; 3: 976-82.
75. Rizoli SB, Scarpelini S, Callum J, Nascimento B, Mann KG, Pinto R, Jansen JO, Tien HC. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma 2011; 71: S427-34.
76. Jansen JO, Scarpelini S, Pinto R, Tien HC, Callum J, Rizoli SB. Hypoperfusion in severely injured trauma patient is associated with reduced coagulation factor activity. J Trauma 2011; 71: S435-40.
77. Johansson PI, Stenballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 2011; 254: 194-200.
78. Nieuwdorp M, van Haeften TW, Gouverneur MCG, Mooij HL, van Lieshout MHP, Levi M, Meijers JCM, Holleman F, Hoekstra JBL, Vink H, Kastelein JJP, Stroes ESG. Loss of endothelial glycocayx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55: 480-6.
79. Cohen MJ, Call M, Nelson M, Calfee CS, Esmon CT, Brohi K, Pittet JF. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg 2012; 255: 379-85.
80. Liaw PCY, Ferrell G, Esmon CT. A monoclonal antibody against activated protein C allows rapid detection of activated protein C in plasma and reveals a calcium ion dependent epitope involved in factor Va inactivation. J Thromb Haemost 2003; 1: 662-70.
81. Yanagida Y, Gando S, Hayakawa M, Sawamura A, Uegaki S, Kubota N, Homma T, Ono Y, Honma Y, Wada T, Jesmin S. Normal prothrombinase activity, increased systemic thrombin generation, and lower antithrombin levels in patients with disseminated intravascular coagulation (DIC) at an early phase of trauma: comparison with acute coagulopathy of trauma-shock (ACOTS). Surgery in press.
82. Risberg B. Fibrinolysis and trauma. Eur J Surg 1978; 10: 373-81.
83. O'Brodovich HM, Andrew M, Gray GW, Coates G. Hypoxia alters blood coagulation during acute decompression in humans. J Appl Physiol 1984; 56: 666-70.
84. Bärtsch P, Haeberli A, Hauser K, Gubser A, Straub PW. Fibrinogenolysis in the absence of fibrin formation in severe hypobaric hypoxia. Aviat Space Environ Med 1988; 59: 428-32.
85. Gando S, Makise H, Tedo I. Variations in wound healing factors in trauma patients. Jpn J Surg 1990; 91: 17-22.
86. Gando S, Tsujinaga H, Takechi S, Tsukamoto M, Makise H, Takamura I, Kitami K, Matsubara I, Ando M, Tedo I. Blood coagulation and fibrinolysis in trauma patients with special reference to FPA and FPBß15-42. Jpn J Acute Med 1987; 11: 221-8.
87. Stump DC, Taylor FB, Nesheim ME, Giles AR, Dzik WH, Bovill EG. Pathologic fibrinolysis as a cause of clinical bleeding. Semin Thromb Haemost 1990; 16: 260-73.
88. Suffredini AF, Harpel JE, Parillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl Med 1989; 320: 1165-72.
89. Gando S, Kameue T, Nanazaki S, Nakanishi Y. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997; 77: 278-83.
90. CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet 2010;376:23-32.
91. CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trial. Lancet 2011; 377: 1096-101.
92. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thromboelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaeth 2008; 100: 792-7.
93. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010; 252: 434-44.